Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Meloni (Pavia, Italy), J. Cifrian (Santander, Spain), A. Pesci (Monza, Italy), R. Coelho (Lisboa, Portugal), M. Mejia (Mexico City, Mexico), F. Bonella (Essen, Germany), J. Perrin (Metz, France), P. Ceruti (Brescia, Italy), R. García-Sevila (Alicante, Spain), E. Bargagli (Firenze, Italy), S. Hirschi (Strasbourg, France), V. Codullo (Pavia, Italy), L. Cavagna (Pavia, Italy). Lung involvement and clinical characteristics in anti-MDA5 positive connective tissue diseases. 3818

Member's Comments

No comment yet.

Related content which might interest you: Evaluation and treatment of interstitial lung involvement in connective tissue diseases: a clinical update Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=27 Year: 2005 The clinical spectrum and pathogenesis of pulmonary manifestations in connective tissue diseases Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=1 Year: 2005 Features of pulmonary involvement in patients with diffuse connective tissue diseases Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011 Lung ultrasound in the evaluation of interstitial lung diseases in the course of connective tissue diseases Source: International Congress 2017 – Rare diseases Year: 2017 Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies Source: International Congress 2016 – Connective tissue disorders Year: 2016 Anti periplakin antibodies in connective tissue-associated lung fibrosis Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Chemical exposure triggering connective tissue disease with lung involvement Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 Clinical features and CT findings of anti-Jo-1 antibody positive interstitial lung disease with or without polymyositis and dermatomyositis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Are there any clinical differences between SSc-ILD and UCTD suspected of SSc -ILD? Source: International Congress 2015 – Connective tissue disorders Year: 2015 The clinical features of 13 patients with interstitial pneumonia with positive anti-glycyl-tRNA synthetase autoantibodies Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Pattern and impact of rheumatology referral in patients with ILD and autoimmune features Source: International Congress 2016 – Connective tissue disorders Year: 2016 Usefulness of a myositis antibody immunoblot in diagnosis of connective tissue disease (CTD) related interstitial lung disease (ILD) Source: International Congress 2014 – ILDs 4 Year: 2014 Clinico-radiological profile of connective tissue diseases related interstitial lung diseases Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020 Lung transplantation for systemic sclerosis and other connective tissue diseases Source: International Congress 2017 – Difficult indications for lung transplantation Year: 2017 Significance of connective tissue disease in a typical UK diffuse parenchymal lung disease clinic Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Connective tissue disease-associated interstitial lung diseases and interstitial pneumonia with autoimmune features: different entities? Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 What if my lung-dominant connective tissue disease (LD-CTD) patient eventually met criteria for a definite CTD: The role of prognosis! Source: International Congress 2015 – Connective tissue disorders Year: 2015 Features of pulmonary involvement in patients with diffuse connective tissue diseases depending on a nosological form Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011 Clinical manifestation and prognostic factor in anti-aminoacyl-tRNA synthetase autoantibodies-associated interstitial lung disease Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013